Reuters logo
BRIEF-Cytori Therapeutics receives key cell therapy patent for scleroderma
2017年7月6日 / 上午11点13分 / 3 个月前

BRIEF-Cytori Therapeutics receives key cell therapy patent for scleroderma

July 6 (Reuters) - Cytori Therapeutics Inc:

* Cytori Therapeutics - receives key cell therapy patent for scleroderma, patent has a term at least through 2034 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below